Another study has tested the efficacy of p21 saRNA in vitro in many different cancer cell lines, including PC3 (prostate), T24 (bladder), ACHN (renal), U2-OS (osteosarcoma), and 293T (embryonic kidney).3 Here, CDKN1A is linked to cancer.